Optim Partners with 21st Century Oncology as the Preferred Vendor for Head and Neck Cancer Endoscopy

The ENTity™ XL Nasopharyngoscope has been selected by the leading health care provider as the preferred choice in technology utilized to diagnose and manage patients with head and neck cancers. STURBRIDGE, Mass., Sept. 7, 2018 -- (Healthcare Sales & Mar... Devices, Oncology Optim LLC, ENTityXL, Nasopharyngoscope, FreedomView, OptiLux
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news